Haploinsufficiency for Odc modifies mouse skin tumor susceptibility

Cancer Research

Volumn 65, Issue 4, 2005, Pages 1146-1149

  Guo, Yongjun ^a   Cleveland, John L ^b   O'Brien, Thomas G ^a  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORNITHINE DECARBOXYLASE; PHORBOL 13 ACETATE 12 MYRISTATE; POLYAMINE; PUTRESCINE; SPERMIDINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TISSUE LEVEL; ENZYME ACTIVITY; EPIDERMIS; EPIDERMIS HYPERPLASIA; FEMALE; HAPLOIDY; HEMIZYGOSITY; HOMOLOGOUS RECOMBINATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN PAPILLOMA; SKIN TUMOR; TREATMENT OUTCOME; WILD TYPE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BIOGENIC POLYAMINES; CARCINOGENS; COCARCINOGENESIS; ENZYME INDUCTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOIDY; MALE; MICE; MICE, INBRED C57BL; ORNITHINE DECARBOXYLASE; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 13944284497     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-3244     Document Type: Article

References (20)

1. O'Brien TG, Simsiman RC, Boutwell RK. Induction of the polyamine biosynthetic enzymes in mouse epidermis by tumor promoting agents. Cancer Res 1975;35:1662-70.
2. O'Brien TG, Simsiman RC, Boutwell RK. Induction of the polyamine biosynthetic enzymes in mouse epidermis and their specificity for tumor promotion. Cancer Res 1975;35:2426-33.
3. Weeks C, Herrmann A, Nelson F, Slaga T. α-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin. Proc Natl Acad Sci U S A 1982;79:6028-32.
4. Takigawa M, Verma A, Simsiman R, Boutwell R. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by α-difluoromethylornithine. Cancer Res 1983;43:3732-8.
5. O'Brien TG, Megosh LC, Gilliard G, Peralta Soler. A Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res 1997;57:2630-7.
6. 1-acetyltransferase to mouse skin increases susceptibility to chemically-induced skin carcinogenesis. Carcinogenesis 2002;23:359-64.
7. Pendeville H, Carpino N, Marine J-C, et al. The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol Cell Biol 2001;21:6549-58.
8. Tabor C, Tabor H. Polyamines. Annu Rev Biochem 1984;53:749-90.
9. Peralta Soler A, Gilliard G, Megosh L, George K, O'Brien TG. Polyamines regulate expression of the neoplastic phenotype in mouse skin. Cancer Res 1998;58:1654-9.
10. Koza RA, Megosh LC, Palmieri M, O'Brien TG. Constitutively elevated levels of ornithine and polyamines in mouse epidermal papillomas. Carcinogenesis (Lond) 1991;12:1619-25.
11. Megosh L, Gilmour SK, Rosson D, et al. Increased skin tumors in transgenic mice which overexpress ornithine decarboxylase. Cancer Res 1995;55:4205-9.
12. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin Carcinogenesis. Cell 1990;1329-37.
13. Smith MK, Trempus CS, Gilmour SK. Co-operation between follicular ornithine decarboxylase and v-Haras induces spontaneous papillomas and malignant conversion in transgenic skin. Carcinogenesis 1998;19:1409-15.
14. Gonzalez G, Byus C. Effect of dietary arginine restriction upon ornithine and polyamine metabolism during two-stage epidermal Carcinogenesis in the mouse. Cancer Res 1991;51:2932-9.
15. Argyris T. Regeneration and the mechanism of epidermal tumor promotion. Crit Rev Toxicol 1985;14:211-58.
16. Meyskens FL, Gerner EW. Development of difluoromethylomithine (DFMO) as a chemoprevention agent. Clin Cancer Res 1999;5:945-51.
17. Hickok NJ, Seppänen PJ, Gunsalus GL, Janne OA. Complete amino acid.-sequence of human omithine decarboxylase deduced from complementary DNA. DNA 1987;6:179-87.
18. Guo Y, Harris R, Rosson D, Boorman D, O'Brien TG. Functional analysis of human ornithine decarboxylase alleles. Cancer Res 2000;60:6314-7.
19. Martinez ME, O'Brien T, Fultz KE, et al. Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proc Natl Acad Sci U S A. 2003;100:7859-64.
20. Visvanathan K, Helzlsouer K, Boorman D, et al. Association among an ornithine decarboxylase polymorphism, androgen receptor (CAG) repeat length and prostate cancer risk. J Urol 2004;171:652-5.